Pulmonary pharmacology and therapeutics

Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET
Mark C. Liu, Elisabeth H. Bel, Oliver Kornmann, Wendy C. Moore, Norihiro Kaneko, Steven G. Smith, Neil Martin, Robert G. Price, Steven W. Yancey, Marc Humbert

ERJ Open Research Jan 2022, 8 (1) 00419-2021; DOI: 10.1183/23120541.00419-2021
Discontinuation of benralizumab in Canadian patients with severe eosinophilic asthma
Stephen G. Noorduyn, Karissa Johnston, Kathy Osenenko, Niroshan Sriskandarajah, Alain Gendron, Lawrence Mbuagbaw

ERJ Open Research Oct 2021, 7 (4) 00465-2021; DOI: 10.1183/23120541.00465-2021
Expanding clinical phage microbiology: simulating phage inhalation for respiratory tract infections
Shira Ben Porat, Daniel Gelman, Ortal Yerushalmy, Sivan Alkalay-Oren, Shunit Coppenhagen-Glazer, Malena Cohen-Cymberknoh, Eitan Kerem, Israel Amirav, Ran Nir-Paz, Ronen Hazan

ERJ Open Research Oct 2021, 7 (4) 00367-2021; DOI: 10.1183/23120541.00367-2021
Normal limits for oscillometric bronchodilator responses and relationships with clinical factors
Kanika Jetmalani, Nathan J. Brown, Chantale Boustany, Brett G. Toelle, Guy B. Marks, Michael J. Abramson, David P. Johns, Alan L. James, Michael Hunter, Arthur W. Musk, Norbert Berend, Claude S. Farah, David G. Chapman, Cindy Thamrin, Gregory G. King

ERJ Open Research Oct 2021, 7 (4) 00439-2021; DOI: 10.1183/23120541.00439-2021
Short-term effects of menthol on walking dyspnoea in patients with COPD: a randomised, single blinded, cross-over study
Guillaume Prieur, Marc Beaumont, Mathieu Delorme, Yann Combret, Clement Medrinal, Roger Hilfiker, Tristan Bonnevie, Francis-Edouard Gravier, Pauline Smondack, Bouchra Lamia, Gregory Reychler

ERJ Open Research Oct 2021, 7 (4) 00450-2021; DOI: 10.1183/23120541.00450-2021
The Children's Anti-inflammatory Reliever (CARE) study: a protocol for a randomised controlled trial of budesonide-formoterol as sole reliever therapy in children with mild asthma
Lee Hatter, Pepa Bruce, Mark Holliday, Augustus J. Anderson, Irene Braithwaite, Andrew Corin, Allie Eathorne, Arthur Grimes, Matire Harwood, Thomas Hills, Ciléin Kearns, Kyley Kerse, John Martindale, Barney Montgomery, Lynn Riggs, Davitt Sheahan, Nick Shortt, Katja Zazulia, Mark Weatherall, David McNamara, Catherine A. Byrnes, Andrew Bush, Stuart R. Dalziel, Richard Beasley

ERJ Open Research Oct 2021, 7 (4) 00271-2021; DOI: 10.1183/23120541.00271-2021
Effective treatment of late-onset noninfectious pulmonary complication with ruxolitinib in an 8-year-old boy
Maria Di Cicco, Ester Del Tufo, Eva Parolo, Mariacristina Menconi, Sayla Bernasconi, Chiara Romei, Alessandro Di Gangi, Beatrice Masini, Diego Peroni, Gabriella Casazza

ERJ Open Research Jul 2021, 7 (3) 00407-2021; DOI: 10.1183/23120541.00407-2021
An open-label study of the tolerability and potential efficacy of memantine for treating refractory chronic cough
Rayid Abdulqawi, Imran Satia, Kimberley J. Holt, Rachel Dockry, Shilpi Sen, Jaclyn A. Smith

ERJ Open Research Jul 2021, 7 (3) 00447-2021; DOI: 10.1183/23120541.00447-2021
Health and functional status of tiotropium/olodaterol-treated patients with COPD: results from the AERIAL® non-interventional study
Adrian Gillissen, Andrea Marseille, Dirk Skowasch, John Ritz, Muriel Mattiucci-Guehlke, Stefan Pabst, Timm Greulich, Rembert Koczulla

ERJ Open Research Jul 2021, 7 (3) 00004-2021; DOI: 10.1183/23120541.00004-2021
Haemodynamic effects of riociguat in CTEPH and PAH: a 10-year observational study
Suqiao Yang, Yuanhua Yang, Yixiao Zhang, Tuguang Kuang, Juanni Gong, Jifeng Li, Yidan Li, Jianfeng Wang, Xiaojuan Guo, Ran Miao

ERJ Open Research Jul 2021, 7 (3) 00082-2021; DOI: 10.1183/23120541.00082-2021

Main menu

User menu

Search

Pulmonary pharmacology and therapeutics

Pages

Contact us